As ERK1/2 phosphorylation was decreased in T-ALL blasts but also in MS5 cells following incubation with the MEKi PD184352 (Fig 2), we investigated whether MEKi effect on T-ALL proliferation was mediated through MS5 cells. The gene discussed is MAPK3; the disease is acute lymphoblastic leukemia.